RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Isotope & Radiation Stock

China Isotope & Radiation Stocks 2024

China Isotope & Radiation Stocks

319.87 M

Ticker

1763.HK

ISIN

CNE1000031F4

In 2024, China Isotope & Radiation had 319.87 M outstanding stocks, a 0% change from the 319.87 M stocks in the previous year.

The China Isotope & Radiation Stocks history

YEARNUMBER OF STOCKS (undefined CNY)
2025e319.87
2024e319.87
2023319.87
2022319.87
2021319.87
2020319.87
2019319.88
2018279.12
2017232.03
2016200
2015200

China Isotope & Radiation shares outstanding

The number of shares was China Isotope & Radiation in 2023 — This indicates how many shares 319.875 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue China Isotope & Radiation earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates China Isotope & Radiation's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of China Isotope & Radiation’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating China Isotope & Radiation's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

China Isotope & Radiation Aktienanalyse

What does China Isotope & Radiation do?

China Isotope & Radiation Corp (CIRC) is a Chinese company specialized in the production and sale of nuclear products and services. It was founded in 1990 and is headquartered in Beijing. CIRC's history dates back to the 1950s when China conducted atomic experiments. In the 1960s, the country began producing radioisotopes for use in medicine, industry, and agriculture. CIRC was later established as a company to organize the production and sale of these products and services. CIRC's business model is based on the production and sale of radioisotopes and their applications in various fields such as medicine, industry, environmental monitoring, and research. The company aims to provide high-quality products and services to meet its customers' needs. CIRC has different divisions focusing on the various applications of radioisotopes. One important division is the medical application, which focuses on the production of radioisotopes for cancer diagnosis and therapy, cardiovascular diseases, and other illnesses. The company also produces radioactive drugs that can be used in the diagnosis and treatment of various diseases. Another important division of CIRC is the industrial application of radioisotopes, which focuses on the measurement of thickness, density, and radiation in various products and materials. The company also offers services in surface treatment and material testing. CIRC is also involved in environmental monitoring, offering products and services for the measurement and monitoring of air, water, and soil pollution. The company is also engaged in research and development, developing new products and applications of radioisotopes. CIRC offers a wide range of products, including various types of radioisotopes, radioactive drugs, radiation measurement devices and systems, as well as instruments and equipment for radioisotope production. CIRC is a leading provider of radioisotopes and related services in China and has a strong presence in other countries as well. The company has established itself as a reliable partner for customers in various industries and is committed to the highest quality and customer satisfaction. China Isotope & Radiation ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating China Isotope & Radiation's Shares Outstanding

China Isotope & Radiation's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in China Isotope & Radiation’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding China Isotope & Radiation’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in China Isotope & Radiation’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about China Isotope & Radiation stock

How many stocks are there of China Isotope & Radiation?

The current number of stocks of China Isotope & Radiation is 319.87 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of China Isotope & Radiation are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of China Isotope & Radiation evolved in recent years?

The number of shares of China Isotope & Radiation has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. China Isotope & Radiation as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of China Isotope & Radiation?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does China Isotope & Radiation pay?

Over the past 12 months, China Isotope & Radiation paid a dividend of 0.48 CNY . This corresponds to a dividend yield of about 5.55 %. For the coming 12 months, China Isotope & Radiation is expected to pay a dividend of 0.51 CNY.

What is the dividend yield of China Isotope & Radiation?

The current dividend yield of China Isotope & Radiation is 5.55 %.

When does China Isotope & Radiation pay dividends?

China Isotope & Radiation pays a quarterly dividend. This is distributed in the months of August, July, July, October.

How secure is the dividend of China Isotope & Radiation?

China Isotope & Radiation paid dividends every year for the past 8 years.

What is the dividend of China Isotope & Radiation?

For the upcoming 12 months, dividends amounting to 0.51 CNY are expected. This corresponds to a dividend yield of 5.89 %.

In which sector is China Isotope & Radiation located?

China Isotope & Radiation is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Isotope & Radiation kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Isotope & Radiation from 11/22/2024 amounting to 0.072 CNY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did China Isotope & Radiation pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of China Isotope & Radiation in the year 2023?

In the year 2023, China Isotope & Radiation distributed 0.44 CNY as dividends.

In which currency does China Isotope & Radiation pay out the dividend?

The dividends of China Isotope & Radiation are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Isotope & Radiation

Our stock analysis for China Isotope & Radiation Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Isotope & Radiation Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.